2 results
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... dose (LD) in most cases ... of patients who are ... the timing and dosing ... Inhibitor #switching #conversion
Concentrated Insulin

Developed with the goal of easing therapy by reducing the volume & number of injections
with the goal of easing ... injections and in some cases ... volume lead to low variability ... lower risk of dosing ... #pharmacology #conversion